A new Anti-Rejection strategy may spare kidney function after liver transplant
Disease control
Not yet recruiting
This phase III trial is testing whether switching liver transplant recipients to an everolimus-based, calcineurin inhibitor-free regimen one year after surgery can better preserve kidney function compared to staying on a low-dose calcineurin inhibitor. The study enrolls 150 adult…
Phase: PHASE3 • Sponsor: Hannover Medical School • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC